CEACAM5 and gastric adenocarcinoma: Consistently, CLDN4 and CEACAM5 mRNA levels are significantly higher in gastric adenocarcinomas compared to normal gastric samples from the large TCGA and GTEx cohorts, with CLDN4 showing higher expression levels than CEACAM5 in normal tissues (Figure 2E).